Replies to post #259218 on Avid Bioservices Inc (CDMO)

[Carboat]

Shareholders own the company not bod and execs. pphm is run like a private company but they are not. As a shareholder you have a right to expect bod to represent them and mgmt. to improve shareholder value. If you choose to not sell for whatever reasons does not mean you forfeit this.
- Shareholders have a right to expect action after a failed trial and 65% loss
- Shareholders have a right to expect action to prevent Russel ejection.
- Shareholders have a right to expect a plan to not get delisted.
- Shareholders have a right to expect the company to have a plan to finance the company some other way than ATM at $.40

[Carboat]

Bavi has proven that it increase survival as no other

Really? It did not increase survival more than control in PIII. It didn't increase survival in 1st line. It didn't increase survival in Pancreatic. It did make mice live longer I suppose. Maybe it should be used in veterinary medicine.

Having no creditors and Avid revenue PPHM is better of then any other small cap to adjust

Certainly not better for shareholders as they dilute dilute dilute.

[pphmtoolong]

Blaming management for the Bavi Sunrise failure is pointless. Blaming the control arm for over-performing is equally pointless. The Bavi-arm Sunrise patients simply did no better than the control arm.

Does the Sunrise failure mean Bavi has not value? No. However, it clearly means Bavi will not receive FDA approval any time soon. Peregrine management needs to swallow this bitter medicine, and they need to change company plans to reflect it.

If Peregrine management doesn't see the need to slash the budget and continue expanding Avid, then they are not as smart as I'd like to think they are.

I don't see how Peregrine can finance the Bavi-immunotherapy campaign to completion without partnering help. However, to get decent partnering terms I believe they need to obtain Phase I or II clinical trial success with Bavi and another immunotherapy. Until that time I hope Peregrine can push the burn rate toward zero.

GLTA, Paul

[bfiest]

I believe in the science and I hold them accountable for making decisions that bring this biologic to market and essentially increase the value of this business. That is how it works here in the US anyway. We do have rights. They do have a fiduciary responsibility. Accountability is critical. Sometimes oversight is needed. It's a position I wish weren't in. I invested in the science and it has not disappointed. I am not interfering in any way at this point. That would not be prudent. Obviously there is a disconnect somewhere looking at the share price and the value they seem to hold. They should be expected to eliminate that disconnect. I know the game. I give them the benefit of the doubt until that benefit is no longer warranted. The structure of this team and the decisions made to date justify at least question. And with all due respect nobody tells me how to handle my investment. There are a number of others that feel the same. I know. They have told me. But you are certainly entitled to your opinion.

[eb0783]

Excellent point CloakedProtector

We do not have to run the company, neither putting all kinds of pressure and extra work on them as with the PPHM shareholder propositions in the past.

I have stated that few times myself but some think otherwise. We don't need to muddy the waters more than they are.

So best is that we do not participate in confusing the cat and keep correcting all the FUD.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121159848

My concerns are about causing more trouble and work, just like another ca would cause. They don't need us to distract them. They have enough issues at hand. I am not in favor of your new project.